ClinicalTrials.Veeva

Menu

Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease

Johns Hopkins University logo

Johns Hopkins University

Status

Invitation-only

Conditions

Primary Progressive Aphasia
Mild Cognitive Impairment
Dementia

Treatments

Other: Computerized Cognitive Training
Device: Active tDCS (tDCS) on DLPFC

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT05978804
R01DC014475 (U.S. NIH Grant/Contract)
NA_00071337-4

Details and patient eligibility

About

The primary objective of this research is to evaluate the effects of non-invasive brain stimulation and computerized cognitive training on executive functioning in individuals with Primary Progressive Aphasia (PPA), mild cognitive impairment (MCI), or dementia. In this study, investigators will use transcranial direct current stimulation (tDCS) to stimulate the left dorsolateral prefrontal cortex (DLPFC). Previous studies have demonstrated that tDCS over the DLPFC led to improvements in attention deficit caused by stroke, Parkinson's Disease, and major depression as well as language deficits caused by neurodegenerative conditions such as primary progressive aphasia or mild cognitive impairment. The investigators seek to expand on this literature by investigating how anodal tDCS paired with and without cognitive training will impact executive functioning in PPA with Frontotemporal Dementia or Alzheimer's Disease pathology and Mild Cognitive Impairment/Alzheimer's Disease (e.g. shifting, updating, monitoring, and manipulation).

Full description

In this within-subject cross-over protocol, all participants will receive both, cognitive training and brain stimulation tDCS. Participants will be randomly assigned to begin with either cognitive training and brain stimulation (dual therapy) or just brain stimulation (monotherapy) and will receive the complementary therapy program in the second round of treatment. During each period of therapy, participants will receive 50 treatment sessions over the course of approximately 10 weeks. The computerized cognitive training and brain stimulation will both be preprogrammed to be done at home by the participant.

Enrollment

50 estimated patients

Sex

All

Ages

50 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must be clinically diagnosed with PPA, fronto-temporal dementia (FTD), MCI or mild Alzheimer's disease (AD). Diagnosis will be based on neuropsychological testing, language testing (most commonly the Western Aphasia Battery), MRI, and clinical assessment.
  • Must be right-handed.
  • Must be proficient in English.
  • Must have a minimum high-school education.

Exclusion criteria

  • Uncorrected visual or hearing impairment by self-report.
  • Stroke/other premorbid neurological disorder affecting the brain.
  • Any other developmental language-based learning disorder other than PPA.
  • Inability to follow directions for baseline tasks.
  • Pre-existing psychiatric disorders such as behavioral disturbances, severe depression, and schizophrenia that do not allow them to comply or follow the study schedule and requirements such as repeated evaluation and therapy will be excluded.

Exclusion Criteria for MRI participation:

  • Severe claustrophobia.
  • Cardiac pacemakers or ferromagnetic implants.
  • Pregnant women.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Active tDCS on the DLPFC + Cognitive Intervention(s)
Experimental group
Description:
Participants will receive active tDCS on DLPFC + Cognitive Intervention(s) first and then receive only active tDCS Intervention after a three-month washout period.
Treatment:
Device: Active tDCS (tDCS) on DLPFC
Other: Computerized Cognitive Training
Active tDCS on the DLPFC only
Experimental group
Description:
Participants will receive active tDCS on the DLPFC-only intervention first and then receive active tDCS + Cognitive Intervention(s) after a three-month washout period.
Treatment:
Device: Active tDCS (tDCS) on DLPFC

Trial contacts and locations

1

Loading...

Central trial contact

Jessica "Jessie" Gallegos; Kyrana Tsapkini, PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems